Boehringer-Ingelheim to Close One of Three API Plants in Petersburg
Over the past several years, Boehringer-Ingelheim has been evaluating the future of their original production facility, Synthesis 1 (S1), in Petersburg, VA, given the age of the facility and the future capacity needs of the Corporation.
The company now has determined that it is not feasible or necessary to keep S1 in operation. Therefore, over the next months, they will be evaluating and planning for the shutdown of this facility mid-year 2013. There are many details involved with this closure including evaluating production commitments, decommissioning equipment, and evaluating resource requirements. At this time, all the details or plans are not in place but it is estimated that 80-100 people will be affected.
The other two production facilities, Synthesis 3 and Synthesis 5 located in the same Petersburg complex, will remain open and active.
“We recognize this change greatly impacts our employees, their families and the community. We have always been committed to taking care of our employees…we are committed to doing the same in this difficult situation. We will work to keep our employees informed as we finalize details and next steps,” according to a press release statement.